US Patent Issued to Precision for Medicine on July 7 for "CBX6 as epigenetic marker for the identification of immune cells, in particular memory B cells" (German Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,674,205, issued on July 7, was assigned to Precision for Medicine GmbH (Berlin).

"CBX6 as epigenetic marker for the identification of immune cells, in particular memory B cells" was invented by Sven Olek (Berlin), Udo Baron (Berlin) and Kati Bourquain (Berlin).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a method, in particular an in vitro method, for identifying memory B cells, comprising analyzing epigenetic modifications/properties of (including the methylation status) of at least one CpG position in the mammalian gene region for Chromobox protein homolog 6 (CBX6), wherein a demethylation or lack of methylation of sai...